Trade Mark Journal No.2025/033 15 August 2025

UK00004244357 5 August 2025 (5)

FYMILSI

International priority date claimed: 5 February 2025 (United States of America) (99030058)

Class 5: Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; stem cells for medical purposes; diagnostic radiopharmaceutical preparations; diagnostic preparations for medical purposes; radiopharmaceutical preparations for the treatment of cancer and immune system related diseases and disorders.

Bristol-Myers Squibb Company

Representative: Sipara Limited